CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.16: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.39%Above 5Y avg (1.94%)
Annual Rate
CNY 0.40Paid annual
Payout Ratio
52.2%Sustainable
Payback Period
41.9 yr
Last Ex-Dividend
May 13, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.79BCNY1.16B · vs all stocks (USD)
Trailing P/E
21.77xRevenue (TTM)
3.41BCNY509.04M · vs all stocks (USD)
Profit Margin
10.20%Beta
0.1200xvs all stocks
52-Week Change
-22.12%vs all stocks
Market Capitalization
7.79BCNY1.16B · vs all stocks (USD)
Enterprise Value
8.09BCNY1.21B · vs all stocks (USD)
Trailing P/E
21.77xForward P/E
14.45xPrice to Sales (TTM)
2.28xPrice to Book (MRQ)
1.62xEnterprise to Revenue
2.37xEnterprise to EBITDA
14.15xGross Margin
39.73%Profit Margin
10.20%Operating Margin
12.67%Return on Assets (TTM)
2.90%Return on Equity (TTM)
7.52%Revenue (TTM)
3.41BCNY509.04M · vs all stocks (USD)
Revenue per Share (TTM)
7.51CNYUpdated Sep 20, 2026Quarterly Revenue Growth
0.90%Gross Profit (TTM)
1.36BCNY202.80M · vs all stocks (USD)
EBITDA (TTM)
455.69MCNY68.00M · vs all stocks (USD)
Net Income (TTM)
348.10MCNY51.94M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-31.50%Operating Cash Flow (TTM)
355.80MCNY53.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
12.58MCNY1.88M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.39%vs all stocks
5-Year Average Dividend Yield
1.94%vs all stocks
Payout Ratio
52.16%Minority Interest (Equity)
481.54MCNYFY2025 · Dec 31, 2025Revenue
3.40BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.00BCNYFY2025 · Dec 31, 2025Gross Profit
1.40BCNYFY2025 · Dec 31, 2025Operating Income
441.81MCNY65.93M · vs all stocks (USD)
Pre-tax Income
470.69MCNYFY2025 · Dec 31, 2025Income Tax Expense
36.22MCNYFY2025 · Dec 31, 2025Net Income
434.47MCNYFY2025 · Dec 31, 2025EBIT
505.85MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
691.25MCNYFY2025 · Dec 31, 2025Research & Development
253.02MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
351.11MCNYFY2025 · Dec 31, 2025Other Operating Expenses
28.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.49MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
35.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.8815CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.8815CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
454.35MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
454.35MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
434.47MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-33.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
444.98MCNYFY2025 · Dec 31, 2025Free Cash Flow
269.15MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
625.52MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
434.47MCNYFY2025 · Dec 31, 2025Other Non-cash Items
35.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.76MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-27.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-175.83MCNYFY2025 · Dec 31, 2025Net Acquisitions
-78.09MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.47BCNYFY2025 · Dec 31, 2025Sale of Investments
2.82BCNYFY2025 · Dec 31, 2025Other Investing Activity
616.21KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
102.22MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.19BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.06BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-167.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-152.62MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-193.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
464.75MSharesUpdated Sep 20, 2026Float Shares
233.30MSharesUpdated Sep 20, 2026% Held by Insiders
50.68%vs all stocks
% Held by Institutions
5.45%vs all stocks
Total Cash (MRQ)
1.55BCNY231.78M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.42CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.62BCNY241.21M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3155xCurrent Ratio (MRQ)
1.62xBook Value per Share (MRQ)
10.37CNYUpdated Sep 20, 2026Total Assets
7.66BCNY1.14B · vs all stocks (USD)
Total Current Assets
3.37BCNYFY2025 · Dec 31, 2025Total Liabilities
2.47BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.28BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
581.68MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.89BCNYFY2025 · Dec 31, 2025Cash
619.12MCNYFY2025 · Dec 31, 2025Cash Equivalents
32.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
651.19MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.04BCNYFY2025 · Dec 31, 2025Accounts Receivable
983.60MCNYFY2025 · Dec 31, 2025Inventory
502.12MCNYFY2025 · Dec 31, 2025Accounts Payable
436.83MCNYFY2025 · Dec 31, 2025Short-term Debt
1.09BCNYFY2025 · Dec 31, 2025Other Current Liabilities
27.91MCNYFY2025 · Dec 31, 2025Long-term Debt
371.01MCNYFY2025 · Dec 31, 2025Common Stock (Book)
464.75MCNYFY2025 · Dec 31, 2025Retained Earnings
2.05BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.18BCNY773.65M · vs all stocks (USD)
Treasury Stock
191.21MCNYFY2025 · Dec 31, 202552-Week Low
13.91CNYUpdated Sep 20, 202652-Week High
22.96CNYUpdated Sep 20, 202652-Week Change
-22.12%vs all stocks
Beta
0.1200xvs all stocks
50-Day MA
17.33CNYUpdated Sep 20, 2026200-Day MA
17.94CNYUpdated Sep 20, 2026Avg 10-Day Volume
4.56MSharesUpdated Sep 20, 2026Avg 30-Day Volume
6.66MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.7700CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.16: safe zoneNotable
Altman Z-Score: 3.16
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Beta Bionics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Replimune Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Harbin Gloria Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chongqing Taiji Industry Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Winsunny Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Warrants Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Five-Star Business Finance Limited
1 interpretationMulti-Year Revenue, Profit, And Income Growth
H. Lundbeck A/S
1 interpretationMulti-Year Revenue, Profit, And Income Growth